EYEN stock forecast
Our latest prediction for Eyenovia, Inc.'s stock price was made on the Oct. 12, 2020 when the stock price was at 3.58$.
In the short term (2weeks), EYEN's stock price should outperform the market by 5.64%. During that period the price should oscillate between -10.30% and +18.40%.
In the medium term (3months), EYEN's stock price should underperform the market by -2.78%. During that period the price should oscillate between -43.45% and +41.57%.Get email alerts
Create a solid portfolio with EYEN
About Eyenovia, Inc.
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.09$ per share.
The book value per share is 2.35$
Three months stock forecastOct. 12, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|